Jonsson Comprehensive Cancer Center
🇺🇸United States
Vaccine Therapy in Treating Patients With Advanced Cancer
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-05-25
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00004881
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Diet and Estrogen Metabolism in Postmenopausal Women
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Other: fat reduction without increased fiberOther: fat reduction with increased fiber
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT00003098
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
Phase 2
Completed
- Conditions
- Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmOral ComplicationsRadiation Toxicity
- First Posted Date
- 2004-05-20
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00004132
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
Phase 1
Completed
- Conditions
- Kidney Cancer
- First Posted Date
- 2004-05-20
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 14
- Registration Number
- NCT00004880
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
Phase 2
Withdrawn
- Conditions
- Graft Versus Host DiseaseLeukemia
- First Posted Date
- 2004-04-28
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00004878
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
Not Applicable
Completed
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00005082
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
Phase 2
Withdrawn
- Conditions
- Liver Cancer
- First Posted Date
- 2004-04-13
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00020774
ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer
Phase 2
- Conditions
- Lung Cancer
- First Posted Date
- 2004-04-13
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00021008
Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
Phase 3
- Conditions
- Colorectal Cancer
- First Posted Date
- 2004-04-13
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00021281
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma
Phase 2
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2004-04-08
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00081042
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath